Estatinas y osteoporosis: una promesa latente

Pacheco-Pantoja, Elda Leonor; Alvarez-Nemegyei, Jose.
Reumatol. clín. (Barc.) ; 10(4): 201-203, jul.-ago. 2014.
Artículo en Español | IBECS (España) | ID: ibc-124006

Documentos relacionados

  1. Targeting vascular calcification: softening-up a hard target.
  2. The osteoclast cytoskeleton - current understanding and therapeutic perspectives for osteoporosis.
  3. Smart osteoclasts targeted nanomedicine based on amorphous CaCO<sub>3</sub> for effective osteoporosis reversal.
  4. Statins-Their Role in Bone Tissue Metabolism and Local Applications with Different Carriers.
  5. Modification of the RANKL-RANK-binding site for the immunotherapeutic treatment of osteoporosis.
  6. Genistein Modified with 8-Prenyl Group Suppresses Osteoclast Activity Directly via Its Prototype but Not Metabolite by Gut Microbiota.
  7. Molecular and Cellular Mechanisms of Osteoporosis.
  8. Statins and Mortality in COPD: A Methodological Review of Observational Studies.
  9. Statins for the Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis.
  10. Statins and venous leg ulcer healing: Secondary analysis of data from a cohort of three randomised controlled trials.